期刊文献+

PAS三联疗法对急性脑梗死患者血清MMP-7、MMP-8水平的影响及颈动脉易损斑块的干预作用 被引量:6

Effect of PAS Triple Therapy on Serum Marix Metalloproteinase-7,-8 and Atherosclerosis in Patients with Acute Cerebral Infarction
原文传递
导出
摘要 目的:探讨普罗布考、阿司匹林、他汀类药物(PAS)三联疗法对急性脑梗死患者血清超敏C-反应蛋白(hs-CRP)、基质金属蛋白酶-7(MMP-7)及基质金属蛋白酶-8(MMP-8)水平的影响,观察其对颈动脉易损斑块的干预作用。方法:135例急性脑梗死患者根据颈动脉超声检查结果分为颈动脉稳定斑块组(n=45)和颈动脉易损斑块组(n=90)。将稳定斑块组作为对照组,易损斑块组根据治疗方法按随机数字法分为AS组45例(阿司匹林100mg/d,阿托伐他汀20mg/d,口服)和PAS组45例(阿司匹林100mg/d,阿托伐他汀20mg/d,普罗布考0.25/次,2次/d,口服)。比较治疗前和治疗4周血清hs-CRP、MMP-7和MMP-8水平;观察治疗前及治疗后12月颈动脉内-中膜厚度(IMT值)、斑块面积及斑块回声变化。结果:治疗前,易损斑块组中两亚组(AS组和PAS组)血清hs-CRP、MMP-7和MMP-8水平均高于稳定斑块组(对照组),差异有显著性(P均<0.01);两组(AS组和PAS组)间血清hs-CRP、MMP-7和MMP-8水平差异无显著性(均P>0.05)。治疗后4周,PAS组中血清hs-CRP、MMP-7和MMP-8水平均低于AS组,其下降幅度均大于AS组,差异具有显著性(P均<0.01);治疗12月后,两组IMT值和斑块面积较治疗前减少,且PAS组两项指标低于AS组,差异具有显著性(P均<0.01);PAS组低回声斑块回声增强例数多于AS组(P<0.01)。结论:PAS三联疗法能迅速降低脑梗死患者血清炎性因子水平,具有更强的抗炎作用,可逆转和稳定斑块。 Objective: To observe the influence of combination therapy of probucol,aspirin and statins drugs(PAS) on inflammatory factors such as high sensitivity C-reactive protein(hs-CRP),marix metalloproteinase-7(MMP-7) and marix metalloproteinase-8(MMP-8) in patients with acute cerebral infarction(ACI) and its effect on the role of carotid artery plaque.Methods: According to the results of carotid artery ultrasound,135 cases of patients with ACI were divided into carotid stable plaque group(n=45) and carotid vulnerable plaque group(n=90).Stable plaque group was considered as control group.Ninety cases with carotid vulnerable plaque were randomly divided into aspirin and statins drugs(AS) group(n=45,aspirin 100 mg/d and atorvastatin 20 mg/d,orally) and PAS group(n=45,aspirin 100 mg/d,atorvastatin 20 mg/d,and probucol 0.25 g,b.i.d.,orally).Serum hs-CRP,MMP-7,and MMP-8 levels were detected in all patients before treatment and four weeks after treatment.The intima-media thickness(IMT),plaque area and echogenicity of carotid plaques in all cases were evaluated by Doppler ultrasonography during a 12-month follow-up period.Results: Before treatment,serum hs-CRP,MMP-7,and MMP-8 levels in two subgroups of vulnerable plaque group(AS group and PAS group) were higher than that in stable plaque group(control group)(all P0.01),while no significant differences were observed between AS group and PAS group(all P0.05).Levels of hs-CRP,MMP-7 and MMP-8 decreased significantly in AS group after 4 weeks,as well as in PAS group(all P0.01).Four weeks later,the hs-CRP,MMP-7 and MMP-8 levels were obviously higher in PAS group than in AS group(all P0.01).Whether in AS or PAS group,significant increase in echogenicity of carotid plaques and decrease in plaque area and IMT were noted after therapy.However,the value of IMT and plaque area were significantly less in PAS group as compared to AS group(both P0.01).The cases with increasing hypoechoic plaques were significantly more in PAS group after treatment than in AS group(P0.01).Conclusion: Combination therapy of probucol,aspirin and statins drugs could rapidly reduce serum inflammatory factors in patients with ACI,and might have stronger anti-inflammation function,so as to reverse or stabilize the atherosclerosis plaque.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2012年第2期219-223,共5页 Medical Journal of Wuhan University
基金 武汉市卫生局科研资助项目(编号:WX10C23)
关键词 脑梗死 阿托伐他汀 普罗布考 基质金属蛋白酶 动脉粥样硬化 Cerebral Infarction Atorvastatin Probucol Marix Metalloproteinase Atherosclerosis
  • 相关文献

参考文献11

  • 1Loftus IM,Naylor AR,Bell PR,et al.Plasma MMP-9-a marker of carotid plaque instability[J].Eur J VascEndovasc Surg,2001,21(1):17-21.
  • 2Orbe J,Fernandez L,Rodríguez JA,et al.Different ex-pression of MMPs/TIMP-1in human atherosclerotic le-sions.Relation to plaque features and vascular bed[J].Atherosclerosis,2003,170(2):269-276.
  • 3Mathiesen EB,Bnaa KH,Joakimsen O.Echolucentplaques are associated with high risk of ischemic cere-brovascular events in carotid stenosis:the tromsstudy[J].Circulation,2001,103(17):2 171-2 175.
  • 4Yamashita T,Hirata K.Anti-inflammatory and im-mune modulation therapy against atherosclerosis[J].Nippon Rinsho,2011,69(1):168-172.
  • 5Wensley F,Gao P,Burgess S,et al.Association be-tween C reactive protein and coronary heart disease:mendelian randomisation analysis based on individualparticipant data[J].BMJ,2011,342(548):1-8.
  • 6Abd TT,Eapen DJ,Bajpai A,et al.The role of C-re-active protein as a risk predictor of coronary atheroscle-rosis:implications from the JUPITER trial[J].CurrAtheroscler Rep,2011,13(2):154-161.
  • 7Devaraj S,Siegel D,Jialal I.Statin therapy in metabol-ic syndrome and hypertension post-JUPITER:what isthe value of CRP[J]?Curr Atheroscler Rep,2011,13(1):31-42.
  • 8Williams H,Johnson JL,Jackson CL,et al.MMP-7mediates cleavage of N-cadherin and promotes smoothmuscle cell apoptosis[J].Cardiovasc Res,2010,87(1):137-146.
  • 9Djuri'cT,Zivkovi'cM,Stankovi'cA,et al.Plasma lev-els of matrix metalloproteinase-8in patients with carot-id atherosclerosis[J].J Clin Lab Anal,2010,24(4):246-251.
  • 10中国缺血性脑卒中和短暂性脑缺血发作二级预防指南2010[J].中华神经科杂志,2010,43(2):154-160. 被引量:953

二级参考文献5

共引文献952

同被引文献67

  • 1王薇薇,王新德.第六届全国脑血管病学术会议纪要[J].中华神经科杂志,2004,37(4):346-348. 被引量:298
  • 2郭林娜,郭红.瑞舒伐他汀治疗脑梗死患者颈动脉斑块疗效观察[J].中国实用神经疾病杂志,2010,13(22):48-50. 被引量:10
  • 3廖铭芳,何以鉴.脑苷肌肽治疗急性脑梗死40例疗效观察[J].现代医院,2006,6(2):16-17. 被引量:10
  • 4万婷玉,张巧俊,袁海峰,赵英贤,吴仲恒,李建刚.急性脑梗死患者血清S100β蛋白和C反应蛋白含量变化的研究[J].临床神经病学杂志,2007,20(1):56-58. 被引量:18
  • 5Varona JF,Guerra JM,Bermejo F,et al. Causes of is- chemic stroke in young adults,and evolution of the etio- logical diagnosis is over the long term[J]. Eur Neurol, 2007,57(3) :212.
  • 6Goncalves FM,Jaeob-Ferreira AL,Gomes VA,et al. In- creased circulating levels of matrixm etalloproteinase (MMP)-8,MMP-9,and pro-inflammatory markers in pa- tients with metabolic syndrome[J]. Clin Chim Acta,2009, 403(1-2) :173-177.
  • 7Peeters W, Moll FL, Vink A, et al. Collagenase matrix metalloproteinase-8 expressed in atherosclerotic carotid plaques is associated with systemic cardiovascular out- come[J]. Eur Heart J,2011,32(18) :2314-2325.
  • 8Krupinski J, Turu MM, Font MA, et al. Increased tissue factor, MMP-8, and D-dimer expression in diabetic pa- tients with unstable advanced carotid atherosclerosis[J]. Vasc Health Risk Manag,2007,3(4) :405-412.
  • 9Bicknell CD,Peck D, Lau NM, et al. The relationship be- tween plasma MMP-1, 7,-8 and -13 levels and embolie potential during carotid endoluminal intervention[J]. Eur J Vase Endovasc Surg, 2004,28 (5) : 500-507.
  • 10Saver JL,Starkman S,Eckstein M,et al.Methodology of the field administration of stroke therapy-magnesium(FAST-MAG)phase 3 trial:part 1-rationale and general methods[J].Int J Stroke,2014,9(2):215.

引证文献6

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部